BIO EARNINGS & CONFERENCES JAN-FEB/2013 Thursday,

New Post Public Reply Private Reply Replies (0) Message Board

Dec 26, 2012 at 10:20 AM

BIO EARNINGS & CONFERENCES JAN-FEB/2013

Thursday, January 3, 2013
10:00am

CLSP -Callisto Pharmaceuticals Annual Stockholders Meeting

Monday, January 7, 2013

ARIA -ARIAD Pharmaceuticals, Inc. at JPMorgan Global Healthcare Conference

PSTI -PLURISTEM LIFE SYS INC at JPMorgan Global Healthcare Conference

Q1 2013 BSDM -BSD Medical Corp Earnings Release

Q1 2013 RPTP -Raptor Pharmaceutical Corp. Earnings Release
11:00am

CELG -Celgene Corp. at JPMorgan Global Healthcare Conference
6:30pm

DNDN -Dendreon Corporation at JPMorgan Global Healthcare Conference
7:30pm

MDVN -Medivation, Inc. at JPMorgan Global Healthcare Conference

Tuesday, January 8, 2013
12:30am

ONXX -Onyx Pharmaceuticals at JPMorgan Global Healthcare Conference
11:00am

OPTR -Optimer Pharmaceuticals Inc at JPMorgan Global Healthcare Conference
12:00pm

AMGN -Amgen at JPMorgan Global Healthcare Conference
5:30pm

LLY -Eli Lilly at JPMorgan Global Healthcare Conference

Wednesday, January 9, 2013
11:00am

PRXL -PAREXEL International at JPMorgan Global Healthcare Conference
4:30pm

ISIS -Isis Pharmaceuticals at JPMorgan Global Healthcare Conference
5:00pm

EXEL -Exelixis, Inc. at JPMorgan Global Healthcare Conference

Thursday, January 10, 2013
4:30pm

INSM -Insmed Incorporated at JPMorgan Global Healthcare Conference

Monday, January 21, 2013

Q4 2012 ABAT -Abbott Earnings Release

Q4 2012 BMY -Bristol-Myers Squibb Earnings Release

Q4 2012 CELG -Celgene Corp. Earnings Release

Q4 2012 JNJ -Johnson & Johnson Earnings Release

Tuesday, January 22, 2013
8:30am

Q4 2012 JNJ -Johnson & Johnson Earnings Conference Call
4:30pm

Q4 2012 ISRG -Intuitive Surgical Earnings Conference Call

Wednesday, January 23, 2013
5:00pm

Q4 2012 AMGN -Amgen Earnings Conference Call

Friday, January 25, 2013

Q4 2012 CPHD -Cepheid Earnings Release
6:30am

Q2 2013 IMGN -ImmunoGen, Inc. Earnings Release
Monday, January 28, 2013

Q2 2013 ARRY -Array BioPharma Inc. Earnings Release

Q2 2013 MYGN -Myriad Genetics Earnings Release

Q4 2012 BIIB -Biogen Idec Inc. Earnings Release

Q4 2012 GILD -Gilead Sciences Earnings Release

Tuesday, January 29, 2013

Q4 2012 LLY -Eli Lilly Earnings Release

Q4 2012 MRK -Merck & Co., Inc. Earnings Release
10:00am

Q4 2012 PFE -Pfizer Earnings Conference Call
Friday, February 1, 2013

Q4 2012 QGEN -QIAGEN N.V. Earnings Release

Monday, February 4, 2013

Q1 2013 TROV -TrovaGene Inc Earnings Release

Q2 2013 TTHI -TRANSITION THERAPEUTICS INC Earnings Release

Q4 2012 ALR -Alere Inc Earnings Release

Q4 2012 CMB -Cambrex Earnings Release

Q4 2012 CRIS -Curis, Inc. Earnings Release

Q4 2012 GHDX -GENOMIC HEALTH INC Earnings Release

Q4 2012 NBIX -Neurocrine Biosciences Earnings Release

Q4 2012 PBTH -Prolor Biotech Inc Earnings Release

Q4 2012 SGMO -Sangamo BioSciences Earnings Release

Tuesday, February 5, 2013

Q4 2012 ALXN -Alexion Pharmaceuticals Earnings Release

Q4 2012 ALNY -Alnylam Pharmaceuticals Earnings Release

Wednesday, February 6, 2013

Q2 2013 CRDC -Cardica, Inc. Earnings Release

Q4 Full Year 2012 GSK -GlaxoSmithKline PLC Earnings Release

Q4 2012 CDXS -Codexis, Inc. Earnings Release

Q4 2012 ILMN -Illumina, Inc. Earnings Release

Thursday, February 7, 2013

Full Year 2012 SNY -Sanofi SA Earnings Release

Q1 2013 ARWR -ARROWHEAD RESH CORP Earnings Release

Q4 2012 EXEL -Exelixis, Inc. Earnings Release
8:00am

AMGN -Amgen 2013 Business Review Day

Friday, February 8, 2013

Q4 2012 AMPE -Ampio Pharmaceuticals Inc Earnings Release

Q4 2012 BIOC -BioClinica, Inc. Earnings Release

Q4 2012 ITMN -InterMune Earnings Release

Q4 2012 VICL -Vical Inc. Earnings Release

Monday, February 11, 2013

Q2 2012 NPHC -Nutra Pharma Corp Earnings Release

Q4 2012 AVEO -AVEO Oncology Earnings Release

Q4 2012 DARA -DARA BioSciences Earnings Release

Q4 2012 DRAD -Digirad Corporation Earnings Release

Q4 2012 FLDM -Fluidigm Corp Earnings Release

Q4 2012 INCY -Incyte Corporation Earnings Release

Q4 2012 NSPH -NANOSPHERE INC Earnings Release

Q4 2012 NEO -Neogenomics Inc Earnings Release

Q4 2012 NVDQ -NOVADAQ TECHNOLOGIES INC Earnings Release

Q4 2012 NPSP -NPS Pharmaceuticals Earnings Release

Q4 2012 RGEN -Regeneron Pharmaceuticals Earnings Release

Tuesday, February 12, 2013

Q4 2012 FOLD -Amicus Therapeutics, Inc. Earnings Release

Thursday, February 14, 2013

Q4 2012 BMRN -BioMarin Pharmaceutical Inc. Earnings Release

Monday, February 18, 2013

Interim 2013 PRAN -Prana Biotechnology Ltd. Earnings Release

Q4 2012 AUXL -Auxilium Pharmaceuticals, Inc. Earnings Release

Q4 2012 CNDO -Coronado Biosciences Earnings Release

Q4 2012 DYAX -Dyax Corp. Earnings Release

Q4 2012 EXAS -EXACT Sciences Corporation Earnings Release

Q4 2012 INFI -Infinity Pharmaceuticals, Inc. Earnings Release

Q4 2012 TRGT -Targacept, Inc. Earnings Release

Tuesday, February 19, 2013

PSTI -PLURISTEM LIFE SYS INC at RRY Publication New York Stem Cell Summit

Q4 2012 SNTA -Synta Pharmaceuticals Corp. Earnings Release

Wednesday, February 20, 2013

Q4 2012 BIO -Bio-Rad Laboratories, Inc. Earnings Release

Q4 2012 SGEN -Seattle Genetics Earnings Release
Thursday, February 21, 2013

Q4 2012 ANTH -ANTHERA PHARMACEUTICALS INC Earnings Release

Q4 2012 OPXA -OPEXA THERAPEUTICS INC Earnings Release

Friday, February 22, 2013

DSCI -Derma Sciences at NPUAP Pressure Ulcer Prevention and Treatment Conference

Q4 2012 ONXX -Onyx Pharmaceuticals Earnings Release

Monday, February 25, 2013

Interim 2013 GENE -Genetic Technologies Ltd Earnings Release

Interim 2013 MBLTY -Mesoblast Ltd Earnings Release

Interim 2013 NVGN -Novogen Ltd Earnings Release

Q4 2012 IPXL -Impax Laboratories Earnings Release

Q4 2012 MDVN -Medivation, Inc. Earnings Release

Q4 2012 MDXG -MIMEDX GROUP INC Earnings Release

Q4 2012 NKTR -NEKTAR THERAPEUTICS Earnings Release

Q4 2012 SRPT -Sarepta Therapeutics Inc Earnings Release

Q4 2012 TZYM -Tranzyme Inc Earnings Release

Wednesday, February 27, 2013

PRXL -PAREXEL International at Citi Global Healthcare Conference

Q4 2012 ANIK -Anika Therapeutics Earnings Release

Q4 2012 ARQL -ArQule, Inc. Earnings Release

Q4 2012 CERS -Cerus Corporation Earnings Release

Q4 2012 DNDN -Dendreon Corporation Earnings Release

Q4 2012 KERX -Keryx Biopharmaceuticals, Inc. Earnings Release

Q4 2012 NAVB -Navidea Biopharmaceuticals Inc Earnings Release

Q4 2012 ZIOP -ZIOPHARM ONCOLOGY INC Earnings Release

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Honeywell's Supply Line Snags Bait Class Action Risk

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

The Real Cost of Cabinet Decisions: Refinish or Replace?

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Trading Platforms Poised for Billions by 2031

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Venice's Climate Challenge: Rising Seas, Sinking Lands

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Govee Stirs Halloween Chills with New Sarah Gellar Ad

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Kal Plastics Showcases at Design-2-Part Expo

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...